Literature DB >> 72599

Cell cycle-related changes in nuclear chromatin of stimulated lymphocytes as measured by flow cytometry.

Z Darzynkiewicz, F Traganos, T K Sharpless, M R Melamed.   

Abstract

Flow cytometric techniques have been developed to assay lymphocyte stimulation as reflected by the increase in the cell transcriptional activity and cell progression through the cell cycle. The metachromatic fluorescent dye, acridine orange, is used to (a) stain DNA and RNA differentially in individual cells, and (b) stain nuclear chromatin after removal of cellular RNA BY RNase and cell pretreatment at acidic pH. Stimulated cells with diploid DNA content (G1) have an increased content of stainable RNA that makes it possible to distinguish them from nonstimulated (G0) cells. G0 cells can also be distinguished from G1 cells based on differences in stainability of their nuclear chromatin after treatment with acid. Mitotic indices can be scored automatically, inasmuch as the metaphase chromatin stains differently than does chromatin in the interphase cells. Altogether, the numbers of cells in the G0, G1, S, G2, and M phases may be obtained rapidly and with great accuracy. The cell transciptional activity can be correlated with changes in nuclear chromatin (e.g., during the transition from G0 to G1). The two independent techniques may also prove to be useful in recognizing and quantitating noncycling cells in other cell systems. The possible mechanisms responsible for differential stainability of nuclear chromatin in cells at different phases of the cell cycle are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72599

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Histochemical study on the maturation of human megakaryocytes using microfluorometry.

Authors:  N Maruo; Y Kobayashi; H Horiuchi; M Kondo; S Fujita
Journal:  Histochemistry       Date:  1992

2.  Advances in cell kinetics.

Authors:  K E Williamson; P W Hamilton; J Grimes; R Gilliland
Journal:  BMJ       Date:  1991-10-05

3.  Control of human B-lymphocyte replication. I. Characterization of novel activation states that precede the entry of G0 B cells into cycle.

Authors:  L Walker; G Guy; G Brown; M Rowe; A E Milner; J Gordon
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

4.  Human epidermal cell cultures: growth and differentiation in the absence of differentiation in the absence of dermal components or medium supplements.

Authors:  M Eisinger; J S Lee; J M Hefton; Z Darzynkiewicz; J W Chiao; E de Harven
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

5.  Subcompartments of the G1 phase of cell cycle detected by flow cytometry.

Authors:  Z Darzynkiewicz; T Sharpless; L Staiano-Coico; M R Melamed
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

6.  Relationship between RNA content and progression of lymphocytes through S phase of cell cycle.

Authors:  Z Darzynkiewicz; D Evenson; L Staiano-Coico; T Sharpless; M R Melamed
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

7.  Cell cycle-specific effects of lovastatin.

Authors:  M Jakóbisiak; S Bruno; J S Skierski; Z Darzynkiewicz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

8.  Specific G1-S phase cell cycle block by beryllium as demonstrated by cytofluorometric analysis.

Authors:  D N Skilleter; R J Price; R F Legg
Journal:  Biochem J       Date:  1983-12-15       Impact factor: 3.857

9.  Optimal conditions in [3H]-thymidine uptake studies to prevent radiation damage to cells. A scintimetric and cytofluorographic analysis.

Authors:  A Ruiz-Arguelles; L Llorente; E Díaz-Jouanen; D Alarcón-Segovia
Journal:  Immunology       Date:  1981-12       Impact factor: 7.397

10.  Nuclei act as independent and integrated units of replication in a Xenopus cell-free DNA replication system.

Authors:  J J Blow; J V Watson
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.